Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fumoleau

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Bulletin Du Cancer|November 6, 2007
[Targeting ErbB receptors in breast cancer]Pierre Fumoleau, Mario Campone, Bruno Coudert, et al.
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in breast cancer]Pierre Fumoleau, Bruno Coudert, Françoise Mayer, et al.
International Journal of Oncology|July 4, 2014
Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterationsSandy Chevrier, Laurent Arnould, François Ghiringhelli, et al.
BMC Cancer|October 9, 2013
Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumoursPierre Fumoleau, Jose Manuel Trigo, Nicolas Isambert, et al.
Investigational New Drugs|October 8, 2005
Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeksPeter Johnson, Thomas Geldart, Pierre Fumoleau, et al.
Cell Adhesion & Migration|February 7, 2017
Exosomes in cancer theranostic: Diamonds in the roughMarine Cordonnier, Gaëtan Chanteloup, Nicolas Isambert, et al.
Critical Reviews in Oncology/Hematology|August 18, 2014
Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?Séverine Guiu, Anita Wolfer, William Jacot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding studyXavier Paoletti, Benoît Baron, Patrick Schöffski, et al.
Cancer Investigation|May 30, 2009
Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinomaRomain Boidot, Frédérique Vegran, Marie-Sophie Soubeyrand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2018
Breast Cancer Blood Flow and Metabolism on Dual-Acquisition <sup>18</sup>F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy ResponseOlivier Humbert, Maud Lasserre, Aurélie Bertaut, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Bulletin Du Cancer|November 6, 2007
[Targeting ErbB receptors in breast cancer]Pierre Fumoleau, Mario Campone, Bruno Coudert, et al.
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in breast cancer]Pierre Fumoleau, Bruno Coudert, Françoise Mayer, et al.
International Journal of Oncology|July 4, 2014
Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterationsSandy Chevrier, Laurent Arnould, François Ghiringhelli, et al.
BMC Cancer|October 9, 2013
Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumoursPierre Fumoleau, Jose Manuel Trigo, Nicolas Isambert, et al.
Investigational New Drugs|October 8, 2005
Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeksPeter Johnson, Thomas Geldart, Pierre Fumoleau, et al.
Cell Adhesion & Migration|February 7, 2017
Exosomes in cancer theranostic: Diamonds in the roughMarine Cordonnier, Gaëtan Chanteloup, Nicolas Isambert, et al.
Critical Reviews in Oncology/Hematology|August 18, 2014
Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?Séverine Guiu, Anita Wolfer, William Jacot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2006
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding studyXavier Paoletti, Benoît Baron, Patrick Schöffski, et al.
Cancer Investigation|May 30, 2009
Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinomaRomain Boidot, Frédérique Vegran, Marie-Sophie Soubeyrand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2018
Breast Cancer Blood Flow and Metabolism on Dual-Acquisition <sup>18</sup>F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy ResponseOlivier Humbert, Maud Lasserre, Aurélie Bertaut, et al.
Pageof 11